Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether General Cannabis is trading at an attractive price based on the cash flow it is expected to produce in the future. But as General Cannabis has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
General Cannabis. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
General Cannabis's earnings available for a low price, and how does
this compare to other companies in the same industry?
General Cannabis has negative assets, we can't compare the value of its assets to the DE Commercial Services industry average.
Take a look at our analysis of 7A7’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through General Cannabis's regulatory filings and announcements.
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as General Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Commercial Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare General Cannabis's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare General Cannabis's earnings growth to the Germany market average as no estimate data is available.
Unable to compare General Cannabis's revenue growth to the Germany market average as no estimate data is available.
Unable to determine if General Cannabis is high growth as no earnings estimate data is available.
Unable to determine if General Cannabis is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
General Cannabis's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
General Cannabis's finances.
The net worth of a company is the difference between its assets and liabilities.
General Cannabis's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
General Cannabis's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
General Cannabis's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
General Cannabis has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Michael R. Feinsod has been Chief Executive Officer of General Cannabis Corp since August 5, 2019. Mr. Feinsod served as Interim Chief Executive Officer at General Cannabis Corp since January 07, 2019 until August 5, 2019. Mr. Feinsod serves as the President of ELK Associates Funding Corporation. Mr. Feinsod served as the Chief Executive Officer of Ameritrans Capital Corp. from October 10, 2008 to July 8, 2013 and served as its President from November 27, 2006 to July 8, 2013, Chief Compliance Officer from July 2008 to July 8, 2013 and also served as its Interim Treasurer since July 2010. Mr. Feinsod served as the Senior Vice President of Elk Associates unding Corporation, a subsidiary of Ameritrans Capital Corp. He served as a Managing Member of Infinity Capital, L.L.C. since January 1999. He served as Interim Chief Financial Officer of Ameritrans Capital Corp. from July 2010 to September 29, 2010. He served as an Investment Analyst and Portfolio Manager of Mark Boyar & Company, Inc. from June 1997 to January 1999. He served as a Secretary of Kingstone Companies, Inc. He has been Executive Chairman of the Board of General Cannabis Corp. since August 4, 2014 and served as its Interim Chief Executive Officer since January 2019. Mr. Feinsod served as the Chairman of Ameritrans Capital Corp. from November 11, 2010 to July 8, 2013. He served as a Director of Kingstone Companies, Inc. since October 23, 2008 until June 6, 2015. He served as a Director of Ameritrans Capital Corp. from December 22, 2005 to July 8, 2013 and Asta Funding Inc., since March 2001. He served as a Director of Elk Associates Funding Corporation, a subsidiary of Ameritrans Capital Corp. from December 2005 to July 8, 2013. He is admitted to practice law in New York and served as Associate in Corporate Law Department at Paul, Hastings, Janofsky & Walker LLP from 1996 to 1997. Mr. Feinsod holds a Juris Doctorate degree from Fordham University School of Law and a Bachelor of Arts from George Washington University.
Michael's compensation has been consistent with company performance over the past year, both up more than 20%.
Michael's remuneration is about average for companies of similar size in Germany.
Management Team Tenure
Average tenure of the
management team in years:
The average tenure for the General Cannabis management team is less than 2 years, this suggests a new team.
Executive Chairman of the Board & CEO
Chief Financial Officer
Vice President of Operations
Vice President of Corporate Development
Managing Director of Chiefton Supply Co
Managing Director of Chiefton Supply
VP & Controller
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the General Cannabis board of directors is about average.
Board of Directors
Executive Chairman of the Board & CEO
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
General Cannabis Corp provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates in four segments: Security and Cash Transportation Services (Security), Operations Consulting and Products (Operations), Consumer Goods and Marketing Consulting (Consumer Goods), and Capital Investments and Real Estate (Investments). The Security segment offers advanced security services, including on-site professional and cash transport to licensed cannabis cultivators and processing facilities, and retail shops; and security services to non-cannabis customers, such as hotels, apartment buildings, and retail. The Operations segment provides consulting services to the cannabis industry comprising obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and construction, and expansion of existing operations. The Consumer Goods segment provides design, branding, and marketing strategy consulting services to the cannabis industry, including sourcing and selling customer-specific apparel and accessories. It offers T-shirts, hats, hoodies, and accessories through an online shop, cannabis and non-cannabis retailers, and specialty T-shirt and gift shops. The Investments segment provides loans or revolving lines of credit; leases real estate properties; and invests in businesses. The company was formerly known as Advanced Cannabis Solutions, Inc. and changed its name to General Cannabis Corp in June 2015. General Cannabis Corp was incorporated in 2013 and is headquartered in Denver, Colorado.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.